Terameprocol

DB12226InvestigationalSmall molecule

Terameprocol has been investigated for the treatment of Brain and Central Nervous System Tumors.

Chemical structure of Terameprocol
Formula / weight
C22H30O4 · 358.478 g/mol (avg)
Code names
EM-1421

Resolves to

Compound
UNII53YET703F2CAS24150-24-1ChEMBLCHEMBL90983PubChem476861
Structure
InChIKeyORQFDHFZSMXRLM-IYBDPMFKSA-NSMILESCOC1=CC=C(C[C@H](C)[C@H](C)CC2=CC=C(OC)C(OC)=C2)C=C1OC
Targets
P08047SP1

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Terameprocol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In